Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details Textual 1)

v3.7.0.1
Stockholders' Equity (Details Textual 1)
1 Months Ended 3 Months Ended 9 Months Ended
Feb. 27, 2017
$ / shares
Mar. 31, 2017
USD ($)
$ / shares
shares
Mar. 31, 2017
USD ($)
$ / shares
shares
Mar. 31, 2016
USD ($)
$ / shares
shares
Mar. 31, 2017
CAD / shares
Jun. 30, 2016
$ / shares
shares
Stockholders Equity Note [Line Items]            
Common stock, par value | $ / shares   $ 0.001 $ 0.001     $ 0.001
Proceeds from the exercise of warrants     $ 545,022 $ 405,183    
Addition cash commission     80,575      
Issuance of cash     582,511      
Gross proceeds of cash     1,903,514      
Increase in accumulated deficit     $ 29,594      
Number of stock options outstanding | shares   1,120,850 1,120,850      
Weighted average contractual term     3 years      
Stock options [Member]            
Stockholders Equity Note [Line Items]            
Number of stock options outstanding | shares   1,120,850 1,120,850     856,250
Aggregate intrinsic value of stock options outstanding   $ 508,255 $ 508,255 396,538    
Aggregate intrinsic value of stock options exercisable   468,674 468,674 $ 396,538    
Unrecognized compensation expense   $ 664,071 664,071      
Aggregate intrinsic value of unvested stock options     $ 85,094      
Amendment shares of stock option exercise price | shares   43,750 43,750      
Recognized as stock option liability     $ 260,969      
Stock options [Member] | 1.50 [Member]            
Stockholders Equity Note [Line Items]            
Exercise price | (per share)   $ 1.50 $ 1.50   CAD 2.00  
Number of stock options outstanding | shares   25,000 25,000      
Warrants [Member]            
Stockholders Equity Note [Line Items]            
Exercise price | (per share) $ 5.93 $ 1.54 $ 1.54   CAD 2  
Warrants expiration date Feb. 27, 2020          
Gross proceeds of cash     $ 192,075      
Term of warrants 180 days          
2015 Investor Warrants [Member]            
Stockholders Equity Note [Line Items]            
Issuance of shares and warrants - net of issue costs, shares | shares       1,069,417    
Common stock shares issued on exercise of warrants | shares       1,069,417    
Common stock, par value | $ / shares       $ 2.40    
Exercise price | $ / shares   $ 3.00 $ 3.00 $ 3.00    
Proceeds from the exercise of warrants       $ 2,566,660    
Warrants expiration date       Jul. 31, 2020    
Sale of stock description     Under the Company's engagement agreements with these placement agents, the Company agreed to pay up to a 7% cash commission and issue warrants to purchase shares of common stock (the "2015 Agent Warrants") up to the number of shares of our common stock equal to 5% of the aggregate number of shares sold in the Offering by such placement agent.      
Total cash commission     $ 80,575      
Gross proceeds of cash   $ 146,250 146,250      
Term of warrants       5 years    
Purchase of shares | $ / shares       $ 0.004    
2015 Agent Warrants [Member]            
Stockholders Equity Note [Line Items]            
Exercise price | $ / shares       $ 3.00    
Proceeds from the exercise of warrants     $ 2,040      
Warrants expiration date       Jul. 15, 2020    
Shares issued for services, shares | shares     23,477      
Investor warrants, description     680 of the 2015 Agent Warrants were exercised at $3.00 per share for cash proceeds of $2,040 and 1,000 of the 2015 Agent Warrants were exercised on a cashless basis for 594 shares of common stock.      
Number of warrants issued | shares     1,000 23,477    
2013 Investor Warrants [Member]            
Stockholders Equity Note [Line Items]            
Exercise price | $ / shares   $ 3.144 $ 3.144      
Gross proceeds of cash   $ 204,659